Clinical Trial Update: Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets [Phase 2]

View source ↗

Summary

Prospective Phase 2 clinical trial evaluating toremifene for desmoid-type fibromatosis. The study includes exploratory identification of potential molecular tar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• FARESTON (toremifene citrate)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Desmoid Type-fibromatosis | Phase 2 | Status: UNKNOWN